Adicet Bio, Inc. (ACET) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Adicet Bio, Inc. (ACET) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

ACET Cash Flow Statement

Adicet Bio, Inc. (ACET) cash flow statement — 18-year operating, investing & financing cash flows

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Cash from Operations	-17.92M	-19.82M	-21.49M	-20.91M	-22.31M	-26.63M	-25.4M	-24.1M	-22.01M	-23.42M	-22.85M	-23.49M	-21.24M	-24.9M	-24.09M	-18.84M	-15.33M	-14.71M	4.11M	-13.44M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16.43%	-245.87%
Operating CF Growth %	19.67%	25.57%	15.38%	13.24%	-1.37%	-13.71%	-11.15%	-2.62%	-3.62%	5.93%	5.17%	-24.68%	-38.56%	-69.32%	-686.94%	-40.11%	-58.28%	-15.08%	127.1%	-0.74%
Net Income	-18.88M	-21.36M	-20.24M	-30.52M	-26.86M	-31.22M	-28.21M	-28.73M	-30.48M	-29.9M	-28.02M	-29.49M	-49.88M	-32.4M	-30.88M	-29.88M	-22M	-22.54M	4.62M	-15.81M
Depreciation & Amortization	-889K	1.2M	1.34M	1.47M	1.57M	1.66M	1.68M	1.62M	1.59M	1.6M	1.65M	1.69M	1.65M	1.51M	1.25M	1.06M	759K	405K	352K	365K
Stock-Based Compensation	1.51M	1.44M	1.3M	5.65M	2.53M	2.91M	3.18M	3.77M	6.78M	6M	5.68M	4.91M	5.56M	5.02M	4.76M	4.25M	4.19M	4.33M	4.35M	4.28M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	-9.75M	19.46M	0	0	0	0	0	0	-159K
Other Non-Cash Items	-6.61M	2M	-47K	-156K	-23K	-37K	-348K	-564K	-4.8M	793K	816K	10.51M	749K	785K	578K	796K	444K	659K	681K	352K
Working Capital Changes	6.95M	-3.11M	-3.84M	2.64M	470K	58K	-1.7M	-206K	4.9M	-1.92M	-2.98M	-1.35M	1.23M	186K	190K	4.93M	1.27M	2.43M	-5.9M	-2.47M
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	29K	-29K	0	185K	-30K
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.79M
Change in Payables	-892K	664K	-1.8M	307K	1.21M	-1.12M	629K	1.15M	728K	-567K	-208K	-1.46M	1.4M	709K	-2.33M	1.15M	1.74M	-574K	-612K	-1.94M
Cash from Investing	11.6M	16.65M	18.88M	-44.53M	16.84M	32.95M	-2.86M	-22.12M	-96.58M	-302K	-239K	-136K	-906K	-1.51M	-1.92M	-6.49M	-4.81M	-2.85M	-2.63M	-3.08M
Capital Expenditures	-56K	-202K	-37K	10K	-209K	-47K	-1.49M	-176K	-401K	-302K	-239K	-136K	-906K	-1.51M	-1.92M	-6.49M	-4.81M	-2.85M	-2.63M	-3.08M
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10.53%	56.29%
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	108M	0	0	2M	0	0	0	11M	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Financing	1K	58K	-65K	75.23M	-150K	267K	-104K	137K	-96.18K	204K	110.97M	76K	-59K	226K	-7K	304K	42.18M	163K	-1.13M	97.46M
Debt Issued (Net)	0	0	0	0	-150K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	0	83K	0	75.23M	0	267K	-104	137K	-96.18K	0	110.92M	157K	-59	0	0	0	43.36M	0	0	94.38M
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	-104	0	-96.18K	0	-141	0	-59	0	-10K	-773K	0	0	-1.11M	0
Other Financing	1K	-25K	-65K	0	0	0	-103.9K	0	0	204K	48K	-81K	-58.94K	226K	-7K	304K	-1.18M	163K	-1.13M	3.09M
Net Change in Cash	-6.32M	-3.11M	-2.67M	9.79M	-5.62M	6.59M	-28.36M	-46.08M	-118.59M	-23.52M	87.88M	-23.55M	-22.2M	-26.18M	-26.02M	-25.02M	22.04M	-17.39M	339K	80.94M
Free Cash Flow	-17.98M	-20.02M	-21.53M	-20.9M	-22.52M	-26.68M	-26.89M	-24.28M	-22.41M	-23.72M	-23.09M	-23.62M	-22.14M	-26.41M	-26.01M	-25.33M	-20.14M	-17.55M	1.47M	-16.52M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5.89%	-302.16%
FCF Growth %	20.16%	24.94%	19.94%	13.91%	-0.49%	-12.46%	-16.46%	-2.77%	-1.19%	10.16%	11.23%	6.73%	-9.96%	-50.43%	-1865.72%	-53.29%	-19.43%	-17.73%	109.32%	-20.55%
FCF per Share	-1.67	-1.86	-2.00	-3.03	-3.96	-4.69	-4.72	-4.42	-3.95	-4.19	-4.67	-8.78	-8.24	-9.84	-9.69	-9.73	-7.74	-7.01	0.51	-7.80
FCF Conversion (FCF/Net Income)	0.95x	0.93x	1.06x	0.69x	0.83x	0.85x	0.90x	0.84x	0.72x	0.78x	0.82x	0.80x	0.43x	0.77x	0.78x	0.63x	0.70x	0.65x	0.89x	0.85x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0